Grantham, Mayo, Van Otterloo & Co (GMO)
RPT

Grantham, Mayo, Van Otterloo & Co (GMO)’s RPT Realty Common Shares of Beneficial Interest (MD) RPT Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio RPT Stock Details RPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,040,244
Closed -$13.3M – 566
2023
Q4 		$13.3M Buy
1,040,244
+272,045
+35% +$3.09M 0.06% 217
2023
Q3 		$8.11M Buy
768,199
+725,883
+1,715% +$7.76M 0.04% 278
2023
Q2 		$442K Buy
42,316
+2,516
+6% +$23.8K ﹤0.01% 570
2023
Q1 		$378K Buy
+39,800
New +$401K ﹤0.01% 592
2021
Q2 		– Sell
-31,300
Closed -$357K – 875
2021
Q1 		$357K Buy
+31,300
New +$330K ﹤0.01% 758

Other funds holding RPT

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s RPT Position: Q1 2024 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of RPT Realty Common Shares of Beneficial Interest (MD) (RPT) in Q1 2024, closing a stake of 1,040,244 shares — an estimated $13.3M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in RPT in Q1 2021 and held it in 5 quarters. The position peaked at $13.3M in Q4 2023. 1 fund tracked by Wall St. Rank holds RPT as of Q1 2024.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining RPT Realty Common Shares of Beneficial Interest (MD) position as of Q1 2024 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,040,244 RPT Realty Common Shares of Beneficial Interest (MD) shares in Q1 2024, an estimated $13.3M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in RPT Realty Common Shares of Beneficial Interest (MD) in Q1 2021 and held it in 5 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s RPT Realty Common Shares of Beneficial Interest (MD) position peaked at $13.3M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held RPT Realty Common Shares of Beneficial Interest (MD) as of Q1 2024.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2024, filed 14 May 2024.